Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | CuttingEdgeInfo Reports | Business Development: Accelerating the Deal (PH118)

Business Development: Accelerating the Deal (PH118)

Close key deals and build a top-flight business development team:

Deal-making is an established strategy for filling company pipelines, raising cash, expanding portfolios and driving long-term revenue. Whether companies forge straightforward licensing agreements or long-term alliances, organizations across the industry depend on other firms’ discovery, development and marketing capabilities to reach a range of different objectives.

Use this report to perfect your team's approach to different elements of the deal-making process. Explore primary data and read other executives' perspectives for a comprehensive look at current business development challenges:

* Align deal making with company and therapeutic franchise strategies

* Win competitive funding and staffing

* Streamline due diligence, early deal evaluation and negotiation

* Build cross-functional excitement for new deals

* Identify red flags and watch for stumbling blocks to deal success

Companies Included in Report

Abbott Labs

Ablynx

ADVENTRX Pharmaceuticals

Allergan

Altus

Amgen

Amylin

AstraZeneca

Bayer Schering

Biogen Idec

Boehringer-Ingelheim

Bristol-Myers Squibb

Caprion Proteomics

Celgene

Cancer Research Technology

Compugen

CytRx

DSM

Eisai

Eli Lilly

Epix

Eurand

Genentech

GlaxoSmithKline

Implicit Bioscience

Janssen-Cilag

King Pharmaceuticals

Lexicon

MedImmune

Merck & Co.

Merck Serono

Nerviano Medical Sciences

Neurochem

Neurogen

Novartis

Novo Nordisk

NPS

Onyx

Pfizer

Primus

Procter & Gamble

Purdue Pharma

Roche

Sanofi-Aventis

Solvay

Valeant Canada

Vifor

Published 2008

174 Pages

400+ Metrics

60+ Charts and Diagrams
Table of Contents
Price: $7,695.00 / €5,147.96

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions